FDA inspection

Angiotech Biomaterials Corporation: FDA inspection ending Nov 18, 2002

FDA inspection 246826 · Voluntary Action Indicated (VAI) · Palo Alto, CA

Key facts

Inspection ID 246826
Firm Angiotech Biomaterials Corporation
FEI number 3002203503
Address 2500 Faber Pl
City Palo Alto
State CA
ZIP 94303-3329
Fiscal year 2003
Inspection end date Nov 18, 2002
Classification Voluntary Action Indicated (VAI)
Project area Product Evaluation: Med Devices
Product type Devices

At a glance

  • 1–9 Citations
  • 1–9 Posted citations
  • No Warning letter followed
  • Yes Form FDA 483 issued
  • No Establishment inspection report (EIR) exists
  • 1–9 Inspections at this FEI

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA inspections

FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.

Source: U.S. Food and Drug Administration (FDA), inspection classification data

Browse all FDA inspections